MediPharm Labs Reports First Quarter Results with Growth in Sales, Margin and EBITDA

TORONTO, May 15, 2023 /CNW/ - MediPharm Labs Corp. a pharmaceutical company specialized in precision-based cannabinoids, today announced its financial results for the three months ended March 31,... | May 15, 2023

Related Keywords

Canada ,Australia ,Brazil ,Germany ,Toronto ,Ontario ,United States ,Canadian ,America ,Greg Hunter ,David Pidduck ,Company Financial ,Medipharm Labs Corp ,Drug Administration ,Cannabis Inc ,Toronto Stock Exchange ,Health Canada ,Pharm Labs ,Select Highlights ,Progress Solidifying Leadership ,Cannabis Based Pharmaceutical Industry ,States Food ,Abbreviated New Drug Application ,Active Pharmaceutical Ingredient ,Investigational New Drug ,Stock Exchange ,Medipharm Labs ,Results Conference ,Good Manufacturing Practices ,Pharmaceutical Drug Establishment Licence ,Good Manufacturing Licence ,Note Regarding Forward Looking ,Employment Standards Act ,Gross Profit ,Adjusted Gross Profit ,Canada Newswire ,Medipharm Labs Corp Stock Exchange ,News ,Information ,Press Release ,Bay ,023 ,Medipharm ,Labs ,Harmaceutical ,Company ,Specialized ,N ,Oday ,Nnounced ,Its ,Financial ,Results ,Or ,The ,Three ,Months ,Nded ,Arch Labs Ca58504d1006 ,